BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 31887307)

  • 1. 2-(5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-N-(2-hydroxyethyl)-2-oxoacetamide (CDMPO) has anti-inflammatory properties in microglial cells and prevents neuronal and behavioral deficits in MPTP mouse model of Parkinson's disease.
    Kim B; Park JY; Cho DY; Ko HM; Yoon SH; Choi DK
    Neuropharmacology; 2020 Apr; 166():107928. PubMed ID: 31887307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of neuroinflammatory responses and behavioral deficits by Ligusticum officinale (Makino) Kitag in stimulated microglia and MPTP-induced mouse model of Parkinson's disease.
    Kim BW; Koppula S; Park SY; Kim YS; Park PJ; Lim JH; Kim IS; Choi DK
    J Ethnopharmacol; 2015 Apr; 164():388-97. PubMed ID: 25449453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
    Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
    J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
    Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
    Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of 1-(5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazol-3-yl)-2-morpholinoethane-1,2-dione analogues and their inhibitory activities with reduced cytotoxicity in lipopolysaccharide-induced BV2 cells.
    Yoon SH; Cho DY; Han JH; Choi DK; Kim E; Park JY
    Bioorg Med Chem Lett; 2023 Jan; 79():129061. PubMed ID: 36371018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Potent PDE10A Inhibitor MP-10 (PF-2545920) Suppresses Microglial Activation in LPS-Induced Neuroinflammation and MPTP-Induced Parkinson's Disease Mouse Models.
    Kim DY; Park JS; Leem YH; Park JE; Kim HS
    J Neuroimmune Pharmacol; 2021 Jun; 16(2):470-482. PubMed ID: 32671618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
    Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G
    Int Immunopharmacol; 2019 Oct; 75():105739. PubMed ID: 31351366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of fasudil on inflammation through PI3K/Akt and Wnt/β-catenin dependent pathways in a mice model of Parkinson's disease.
    Zhao Y; Zhang Q; Xi J; Xiao B; Li Y; Ma C
    Int J Clin Exp Pathol; 2015; 8(3):2354-64. PubMed ID: 26045742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Squamosamide derivative FLZ protects dopaminergic neurons against inflammation-mediated neurodegeneration through the inhibition of NADPH oxidase activity.
    Zhang D; Hu X; Wei SJ; Liu J; Gao H; Qian L; Wilson B; Liu G; Hong JS
    J Neuroinflammation; 2008 May; 5():21. PubMed ID: 18507839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson's disease: possible involvement of different binding sites at the PPARγ receptor.
    García C; Gómez-Cañas M; Burgaz S; Palomares B; Gómez-Gálvez Y; Palomo-Garo C; Campo S; Ferrer-Hernández J; Pavicic C; Navarrete C; Luz Bellido M; García-Arencibia M; Ruth Pazos M; Muñoz E; Fernández-Ruiz J
    J Neuroinflammation; 2018 Jan; 15(1):19. PubMed ID: 29338785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Inflammatory and Anti-Migratory Activities of Isoquinoline-1-Carboxamide Derivatives in LPS-Treated BV2 Microglial Cells via Inhibition of MAPKs/NF-κB Pathway.
    Do HTT; Bui BP; Sim S; Jung JK; Lee H; Cho J
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32230861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.
    Yao L; Ye Y; Mao H; Lu F; He X; Lu G; Zhang S
    J Neuroinflammation; 2018 Jan; 15(1):13. PubMed ID: 29329581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LXW7 attenuates inflammation via suppressing Akt/nuclear factor kappa B and mitogen-activated protein kinases signaling pathways in lipopolysaccharide-stimulated BV2 microglial cells.
    Peng S; Jia J; Sun J; Xie Q; Zhang X; Deng Y; Yi L
    Int Immunopharmacol; 2019 Dec; 77():105963. PubMed ID: 31732449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease.
    Jiang J; Kim JJ; Kim DY; Kim MK; Oh NH; Koppula S; Park PJ; Choi DK; Shin YK; Kim IH; Kang TB; Lee KH
    J Ethnopharmacol; 2012 Dec; 144(3):506-13. PubMed ID: 23085397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-arrestin2 regulates the anti-inflammatory effects of Salmeterol in lipopolysaccharide-stimulated BV2 cells.
    Sharma M; Flood PM
    J Neuroimmunol; 2018 Dec; 325():10-19. PubMed ID: 30352316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Hydroxy-4-Methylbenzoic Anhydride Inhibits Neuroinflammation in Cellular and Experimental Animal Models of Parkinson's Disease.
    Song SY; Kim IS; Koppula S; Park JY; Kim BW; Yoon SH; Choi DK
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33147699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The phosphodiesterase 10 inhibitor papaverine exerts anti-inflammatory and neuroprotective effects via the PKA signaling pathway in neuroinflammation and Parkinson's disease mouse models.
    Lee YY; Park JS; Leem YH; Park JE; Kim DY; Choi YH; Park EM; Kang JL; Kim HS
    J Neuroinflammation; 2019 Dec; 16(1):246. PubMed ID: 31791357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease.
    Ghosh A; Langley MR; Harischandra DS; Neal ML; Jin H; Anantharam V; Joseph J; Brenza T; Narasimhan B; Kanthasamy A; Kalyanaraman B; Kanthasamy AG
    J Neuroimmune Pharmacol; 2016 Jun; 11(2):259-78. PubMed ID: 26838361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial Drug Artemether Inhibits Neuroinflammation in BV2 Microglia Through Nrf2-Dependent Mechanisms.
    Okorji UP; Velagapudi R; El-Bakoush A; Fiebich BL; Olajide OA
    Mol Neurobiol; 2016 Nov; 53(9):6426-6443. PubMed ID: 26607631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steppogenin Isolated from Cudrania tricuspidata Shows Antineuroinflammatory Effects via NF-κB and MAPK Pathways in LPS-Stimulated BV2 and Primary Rat Microglial Cells.
    Kim DC; Quang TH; Oh H; Kim YC
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29207498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.